DRUG
DRUG
NASDAQ · Biotechnology

Bright Minds Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$60.66
+1.14 (+1.92%)
As of Jun 21, 10:11 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -55.6% upside
Low Target $16.82
Average Target $26.95
High Target $32.06
Current Price $60.66
Current
$60.66
Target
$26.95
$16.82 $26.95 avg $32.06
Scenario Analysis
Bear Case
$16.82
-72.3%
Low target
Base Case
$26.95
-55.6%
Avg target
Bull Case
$32.06
+-47.1%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$170.00
-64.3% from high
52-Week Low
$33.01
+83.8% from low
Target vs 52W High
$26.95
-84.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%